GlassScriptPhysician profile
Wilson Tsai
NPI 1609035666
$680,055.54
in general payments reported to CMS, 2019-2025
41 companies · $33K in 2025
The $33K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125K · 2020: $123K · 2021: $83K · 2022: $83K · 2023: $135K · 2024: $99K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $93K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59K · Education: $52K · Travel and Lodging: $45K · Food and Beverage: $17K · Gift: $43.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $93,090.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,566.04 |
| Education | $52,068.49 |
| Travel and Lodging | $45,451.85 |
| Food and Beverage | $17,372.84 |
| Gift | $43.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $380,044.48 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Ethicon INC. | $110,082.27 | 2019-2024 | Monarch Platform, Axert |
| Medical Device Business Services, INC. | $32,787.22 | 2019-2024 | Monarch, Monarch Platform, Echelon Flex |
| Pinnacle Biologics, INC | $26,254.03 | 2019-2025 | Photofrin |
| Davol INC. | $24,006.16 | 2019-2025 | Phasix Mesh |
| Ambu INC. | $23,813.89 | 2021-2022 | |
| Noah Medical Corporation | $23,662.49 | 2023-2024 | Galaxy |
| Ethicon US, LLC | $19,217.01 | 2019-2023 | Echelon Endopath, Echelon Flex, Monarch Platform |
| Ethicon Endo-Surgery INC. | $16,349.85 | 2022 | |
| Body Vision Medical INC. | $12,676.60 | 2022-2023 | Lungvision |
| Atricure, INC. | $3,182.33 | 2020-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Mauna Kea Technologies, INC. | $2,159.82 | 2020-2022 | |
| Tela Bio, INC. | $1,344.27 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Becton, Dickinson and Company | $986.06 | 2024 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $932.17 | 2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $341.87 | 2019-2022 | |
| Galvanize Therapeutics, INC | $293.41 | 2023-2024 | Aliya System |
| Olympus America INC. | $279.19 | 2019-2023 | Hanarostent Lowaxtm Duodenum/Pylorus(Nnn), Single Use Suction Valve (Sterile) |
| Pulmonx Corporation | $246.54 | 2024-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Dilon Technologies, INC. | $244.01 | 2023 | Hemoblast Bellows |
| Siemens Medical Solutions USA, INC. | $143.18 | 2024 | Cios Spin |
| Teleflex LLC | $134.62 | 2024 | Quikclot, Titan Sgs |
| Astrazeneca Pharmaceuticals LP | $132.81 | 2019-2025 | Imfinzi |
| Galderma Laboratories, L.P. | $127.83 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $114.62 | 2023 | Opdivo |
| Novocure INC. | $83.17 | 2020 | |
| Covidien LP | $52.73 | 2019 | |
| Abbvie INC. | $52.54 | 2023 | Natrelle Saline-Filled Breast Implants, Botox |
| Mimedx Group, INC. | $44.59 | 2025 | |
| Philips North America LLC | $43.22 | 2022 | |
| Medtronic, INC. | $41.26 | 2022 | |
| Hemosonics LLC | $31.95 | 2020 | |
| Avanos Medical | $30.04 | 2022 | |
| Laborie Medical Technologies Corp. | $29.26 | 2025 | |
| On Target Laboratories, INC | $27.91 | 2024 | Cytalux |
| Nevro Corp. | $18.03 | 2019 | |
| Mallinckrodt Enterprises LLC | $15.81 | 2019 | |
| Octapharma USA, INC. | $15.52 | 2025 | Fibryga |
| Janssen Pharmaceuticals, INC | $12.78 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.